Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • Catalyst Pharma management update

    Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX), Coral Gables, Fla. Business: Neurology Promoted: David Muth to EVP and chief commercial officer, a newly created position, from EVP of corporate development

    Published on 1/12/2015
  • Cepheid management update

    Cepheid Inc. (NASDAQ:CPHD), Sunnyvale, Calif. Business: Microfluidics, Diagnostic, Pharmacogenetics Departing: Andrew Miller as EVP and CFO, effective Feb. 3; he is succeeded by VP and Corporate Controller Daniel Madden…

    Published on 1/12/2015
  • Columbia Laboratories management update

    Columbia Laboratories Inc. (NASDAQ:CBRX), Boston, Mass. Business: Genitourinary, Endocrine/Metabolic Hired: Bridget Martell as CMO, a newly created position, formerly managing director at BAM Consults LLC

    Published on 1/12/2015
  • CytomX management update

    CytomX Therapeutics Inc., South San Francisco, Calif. Business: Antibodies, Cancer, Autoimmune Hired: Michael Kavanaugh as head of research and early development and CSO, formerly SVP and CSO of Five Prime Therapeutics …

    Published on 1/12/2015
  • diaDexus management update

    diaDexus Inc. (OTCBB:DDXS), South San Francisco, Calif. Business: Diagnostic Hired: Kenneth Fang as CMO, formerly VP of translational research and clinical development and CMO of Integrated Diagnostics Inc. Resigned: …

    Published on 1/12/2015
  • Echo Therapeutics management update

    Echo Therapeutics Inc. (NASDAQ:ECTE), Philadelphia, Pa. Business: Drug delivery, Diagnostic Hired: Alan Schoenbart as secretary and CFO, formerly CFO of Forticell Bioscience Inc.

    Published on 1/12/2015
  • Galmed Pharmaceuticals management update

    Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD), Tel Aviv, Israel Business: Hepatic, Endocrine/Metabolic Hired: Josh Blacher as CFO, formerly director of business development at Teva Pharmaceutical Industries Ltd.s Innovative…

    Published on 1/12/2015
  • Halozyme management update

    Halozyme Therapeutics Inc. (NASDAQ:HALO), San Diego, Calif. Business: Endocrine/Metabolic, Cancer, Dermatology Hired: Athena Countouriotis as CMO, formerly CMO of Ambit Biosciences Corp., which Daiichi Sankyo Co. Ltd. …

    Published on 1/12/2015
  • Immunomedics management update

    Immunomedics Inc. (NASDAQ:IMMU), Morris Plains, N.J. Business: Autoimmune, Cancer, Antibodies Hired: Francois Wilhelm as CMO, formerly SVP and CMO of Onconova Therapeutics Inc.

    Published on 1/12/2015
  • Isis Pharmaceuticals management update

    Isis Pharmaceuticals Inc. (NASDAQ:ISIS), Carlsbad, Calif. Business: Cancer, Endocrine/Metabolic, Cardiovascular Hired: Sarah Boyce as CBO, a newly created position, formerly VP and head of international business …

    Published on 1/12/2015
  • Meditope management update

    Meditope Biosciences Inc., Pasadena, Calif. Business: Antibodies, Cancer Transitioned: Bob McKenzie to EVP of business development, while remaining a director

    Published on 1/12/2015
  • Navidea management update

    Navidea Biopharmaceuticals Inc. (NYSE-M:NAVB), Dublin, Ohio Business: Diagnostic Hired: Thomas Klima as SVP and chief commercial officer, formerly head of sales at Algeta ASA, which Bayer AG acquired; and Michael …

    Published on 1/12/2015
  • NeoStem management update

    NeoStem Inc. (NASDAQ:NBS), New York, N.Y. Business: Gene/Cell therapy, Supply/Service Hired: David Mazzo as CEO and a director, formerly CEO and a director of Regado Biosciences Inc., he succeeds Robin Smith, who …

    Published on 1/12/2015
  • Onkaido Therapeutics management update

    Onkaido Therapeutics LLC, Cambridge, Mass. Business: Cancer Hired: Michael Morin as CSO, formerly VP of global R&D at Pfizer Inc.

    Published on 1/12/2015
  • Personal Genome Diagnostics management update

    Personal Genome Diagnostics Inc., Baltimore, Md. Business: Diagnostic Hired: Jeffrey Boschwitz as COO, formerly EVP of operations and corporate development at Plus Diagnostics

    Published on 1/12/2015
  • QLT management update

    QLT Inc. (TSX:QLT; NASDAQ:QLTI), Vancouver, Beta.C. Business: Ophthalmic, Drug delivery Hired: Glen Ibbott as VP of finance, effective immediately, and as interim CFO, effective Jan. 26, formerly VP of finance at …

    Published on 1/12/2015
  • Raptor management update

    Raptor Pharmaceutical Corp. (NASDAQ:RPTP), Novato, Calif. Business: Neurology, Endocrine/Metabolic, Renal Hired: Krishna Polu as CMO, formerly CMO of CytomX Therapeutics Inc.; and Michael Smith as CFO, formerly chief …

    Published on 1/12/2015
  • Salix management update

    Salix Pharmaceuticals Ltd. (NASDAQ:SLXP), Raleigh, N.C. Business: Autoimmune, Infectious, Gastrointestinal Retiring: Carolyn Logan as president, CEO and a director, effective Jan. 30; she will be succeeded by Chairman …

    Published on 1/12/2015
  • Scioderm management update

    Scioderm LLC, Raleigh, N.C. Business: Dermatology, Autoimmune Hired: Ian Howes as CFO, formerly VP of corporate development and CFO of Akebia Therapeutics Inc.

    Published on 1/12/2015
  • Signal Genetics management update

    Signal Genetics Inc. (NASDAQ:SGNL), New York, N.Y. Business: Pharmacogenetics, Diagnostic Hired: Sudipto Sur as chief information officer, formerly president of Anssur Corp.

    Published on 1/12/2015
  • Sprout Pharmaceuticals management update

    Sprout Pharmaceuticals Inc., Raleigh, N.C. Business: Genitourinary Transitioned: Cindy Whitehead to CEO from president and COO; she succeeds Bob Whitehead, who becomes vice chairman and executive director

    Published on 1/12/2015
  • Surface Oncology board of directors update

    Surface Oncology Inc., Cambridge, Mass. Business: Cancer Appointed: Robert Garland, partner at New Enterprise Associates; Armen Shanafelt, general partner at Lilly Ventures; and Robert Weisskoff, partner at Fidelity …

    Published on 1/12/2015
  • ThromboGenics management update

    ThromboGenics N.V. (Euronext:THR), Leuven, Belgium Business: Cardiovascular, Ophthalmic Hired: Dominique Vanfleteren as CFO, formerly CFO of UCB Groups Asia Pacific operations

    Published on 1/12/2015
  • Tute Genomics management update

    Tute Genomics Inc., Salt Lake City, Utah Business: Genomics Hired: David Mittelman as CSO, formerly CSO of Gene by Gene Ltd.

    Published on 1/12/2015
  • Zynerba management update

    Zynerba Pharmaceuticals Inc., Radnor, Pa. Business: Autoimmune, Neurology, Drug delivery Hired: Richard Baron as VP and CFO, formerly SVP and CFO of Globus Medical Inc.

    Published on 1/12/2015

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993